BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 25545309)

  • 41. Serum anti-Müllerian hormone and insulin resistance in the main phenotypes of non-obese polycystic ovarian syndrome women in China.
    Tian X; Ruan X; Mueck AO; Wallwiener D; Wang J; Liu S; Yin D; Lu Y; Zhang Y; Wu H
    Gynecol Endocrinol; 2014 Nov; 30(11):836-9. PubMed ID: 25045796
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ovarian reserve in women with polycystic ovary syndrome who underwent laparoscopic ovarian drilling.
    Weerakiet S; Lertvikool S; Tingthanatikul Y; Wansumrith S; Leelaphiwat S; Jultanmas R
    Gynecol Endocrinol; 2007; 23(8):455-60. PubMed ID: 17852413
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictive markers for the FSH sensitivity of women with polycystic ovarian syndrome.
    Köninger A; Sauter L; Edimiris P; Kasimir-Bauer S; Kimmig R; Strowitzki T; Schmidt B
    Hum Reprod; 2014 Mar; 29(3):518-24. PubMed ID: 24419495
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of metformin on serum insulin and anti-Mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome.
    Nascimento AD; Silva Lara LA; Japur de Sá Rosa-e-Silva AC; Ferriani RA; Reis RM
    Gynecol Endocrinol; 2013 Mar; 29(3):246-9. PubMed ID: 23194004
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relative importance of AMH and androgens changes with aging among non-obese women with polycystic ovary syndrome.
    Kushnir VA; Halevy N; Barad DH; Albertini DF; Gleicher N
    J Ovarian Res; 2015 Jul; 8():45. PubMed ID: 26156856
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of women with elevated antimüllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes.
    Tal R; Seifer DB; Khanimov M; Malter HE; Grazi RV; Leader B
    Am J Obstet Gynecol; 2014 Jul; 211(1):59.e1-8. PubMed ID: 24593938
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Advantages of Serum Anti-Müllerian Hormone as a Marker for Polycystic Ovarian Syndrome.
    Shi X; Peng D; Liu Y; Miao X; Ye H; Zhang J
    Lab Med; 2019 Jul; 50(3):236-242. PubMed ID: 30535164
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of electro-acupuncture and physical exercise on hyperandrogenism and oligo/amenorrhea in women with polycystic ovary syndrome: a randomized controlled trial.
    Jedel E; Labrie F; Odén A; Holm G; Nilsson L; Janson PO; Lind AK; Ohlsson C; Stener-Victorin E
    Am J Physiol Endocrinol Metab; 2011 Jan; 300(1):E37-45. PubMed ID: 20943753
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential rate in decline in ovarian reserve markers in women with polycystic ovary syndrome compared with control subjects: results of a longitudinal study.
    Ahmad AK; Kao CN; Quinn M; Lenhart N; Rosen M; Cedars MI; Huddleston H
    Fertil Steril; 2018 Mar; 109(3):526-531. PubMed ID: 29428308
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.
    Pierre A; Peigné M; Grynberg M; Arouche N; Taieb J; Hesters L; Gonzalès J; Picard JY; Dewailly D; Fanchin R; Catteau-Jonard S; di Clemente N
    Hum Reprod; 2013 Mar; 28(3):762-9. PubMed ID: 23321213
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of cancer treatment on risk of infertility and diminished ovarian reserve in women with polycystic ovary syndrome.
    Shandley LM; Fothergill A; Spencer JB; Mertens AC; Cottrell HN; Howards PP
    Fertil Steril; 2018 Mar; 109(3):516-525.e1. PubMed ID: 29428311
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low vitamin D3 and high anti-Müllerian hormone serum levels in the polycystic ovary syndrome (PCOS): Is there a link?
    Cappy H; Giacobini P; Pigny P; Bruyneel A; Leroy-Billiard M; Dewailly D; Catteau-Jonard S
    Ann Endocrinol (Paris); 2016 Oct; 77(5):593-599. PubMed ID: 26997468
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating Anti-Müllerian Hormone Levels in Daughters of Women with and without Polycystic Ovary Syndrome.
    Olszanecka-Glinianowicz M; Zachurzok A; Drosdzol-Cop A; Bożętowicz-Wikarek M; Owczarek A; Gawlik A; Chudek J; Skrzypulec-Plinta V; Małecka-Tendera E
    Horm Res Paediatr; 2016; 85(6):372-8. PubMed ID: 27173495
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome.
    Du DF; Li XL; Fang F; Du MR
    Gynecol Endocrinol; 2014; 30(12):885-9. PubMed ID: 25170777
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-Mullerian hormone and insulin resistance in polycystic ovary syndrome.
    Fonseca HP; Brondi RS; Piovesan FX; Miklos TG; Aldrighi JM
    Gynecol Endocrinol; 2014 Sep; 30(9):667-70. PubMed ID: 24898132
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Can we use serum Anti-Mullerian hormone to differentiate the diagnosis between polycystic ovary syndrome patients and healthy women with polycystic ovarian morphology and regular menstrual cycles.
    Aydoğmuş H; Kelekçi S; Elmalı F; Aydoğmuş S
    Saudi Med J; 2018 Oct; 39(10):1011-1016. PubMed ID: 30284584
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of serum anti-Müllerian hormone (AMH) in the hormonal diagnosis of polycystic ovary syndrome.
    Casadei L; Madrigale A; Puca F; Manicuti C; Emidi E; Piccione E; Dewailly D
    Gynecol Endocrinol; 2013 Jun; 29(6):545-50. PubMed ID: 23506275
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology.
    Bayrak A; Terbell H; Urwitz-Lane R; Mor E; Stanczyk FZ; Paulson RJ
    Fertil Steril; 2007 Apr; 87(4):870-5. PubMed ID: 17224152
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Revised criteria for PCOS in WHO Group II anovulatory infertility - a revival of hypothalamic amenorrhoea?
    Lauritsen MP; Pinborg A; Loft A; Petersen JH; Mikkelsen AL; Bjerge MR; Nyboe Andersen A
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):584-91. PubMed ID: 25262871
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Polycystic Ovary-Like Abnormalities (PCO-L) in women with functional hypothalamic amenorrhea.
    Robin G; Gallo C; Catteau-Jonard S; Lefebvre-Maunoury C; Pigny P; Duhamel A; Dewailly D
    J Clin Endocrinol Metab; 2012 Nov; 97(11):4236-43. PubMed ID: 22948766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.